Non-invasive decision support for NSCLC treatment using PET/CT radiomics

Two major treatment strategies employed in non-small cell lung cancer, NSCLC, are tyrosine kinase inhibitors, TKIs, and immune checkpoint inhibitors, ICIs. The choice of strategy is based on heterogeneous biomarkers that can dynamically change during therapy. Thus, there is a compelling need to iden...

Descripción completa

Detalles Bibliográficos
Autores principales: Mu, Wei, Jiang, Lei, Zhang, JianYuan, Shi, Yu, Gray, Jhanelle E., Tunali, Ilke, Gao, Chao, Sun, Yingying, Tian, Jie, Zhao, Xinming, Sun, Xilin, Gillies, Robert J., Schabath, Matthew B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567795/
https://www.ncbi.nlm.nih.gov/pubmed/33067442
http://dx.doi.org/10.1038/s41467-020-19116-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567795/
https://www.ncbi.nlm.nih.gov/pubmed/33067442
http://dx.doi.org/10.1038/s41467-020-19116-x

Ejemplares similares